Clinical Trials Browser

HER2-positive Breast Cancer × liposomal doxorubicin × Breast × Clear all

NCT03933319 2020-07-08

Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer

Phase 2 Unknown

HER2-positive Breast Cancer